Our genetics and molecular pathology laboratories were merged into one laboratory operation under the Knight Cancer Institute in January 2011. Specializing in oncology, rare genetic disorders, and infectious disease, the laboratories are CLIA certified and CAP accredited. Our Medical Directors and seasoned technical staff have many years of experience in clinical testing and test development and are dedicated to providing the best quality service for physicians and their patients.
The collaboration of the Knight Diagnostic Laboratories, the Immune Monitoring and Cancer Omics program, Knight BioLibrary and Histopathology Shared Resource Laboratories, offers research investigators access to human biological specimens, advanced research analytics, histology, and immunohistochemistry services.